OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BEEZ56

Beezaasan Explotech Ltd

Commodity ChemicalsVerified

Beezaasan Explotech has a liquidity position characterized by a current ratio of 3.45, indicating a strong ability to meet short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The debt-to-equity ratio of 0.25 suggests a relatively conservative capital structure, with equity financing playing a dominant role in the company's capital base. In terms of profitability, the company's return on equity (ROE) of 13.55% and return on assets (ROA) of 10.01% are strong indicators of efficient use of equity and assets to generate profits. These metrics are well above the typical thresholds for the Commodity Chemicals industry, suggesting that Beezaasan Explotech is outperforming its peers in terms of profitability. The company's revenue is primarily concentrated in the Indian market, with a significant portion of its business tied to the cement, mining, and defense industries. It supplies to the Border Roads Organization and Public Sector Undertakings, indicating a strong government and public sector presence. This concentration may pose risks if demand from these sectors fluctuates. Looking at the growth trajectory, Beezaasan Explotech has demonstrated a consistent revenue stream, with a revenue of INR 2,149,950,870. The company's operating cash flow of INR 51,075,310 and free cash flow of INR 93,221,560 indicate a healthy cash generation capability, which supports its capital expenditure of INR -72,105,020. These figures suggest that the company is investing in its operations to sustain and potentially accelerate growth. The risk assessment for Beezaasan Explotech highlights a medium liquidity risk and a low dilution risk. The company's capital structure is relatively stable, with a low probability of near-term dilution. However, the negative net cash position after subtracting total debt is a key flag that investors should monitor closely. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on its core business of manufacturing and supplying explosives, with no major new initiatives or strategic shifts reported in the latest filings.

30-day price · BEEZ+36.80 (+19.2%)
Low$177.05High$243.00Close$228.05As of17 May, 00:00 UTC
Profile
CompanyBeezaasan Explotech Ltd
TickerBEEZ.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Beezaasan Explotech Limited is an India-based explosive production company engaged in manufacturing and supplying a range of explosives and explosive accessories, primarily cartridge explosives, which include slurry explosives, emulsion explosives, and detonating fuses.

Classification. Beezaasan Explotech is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Beezaasan Explotech has a liquidity position characterized by a current ratio of 3.45, indicating a strong ability to meet short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The debt-to-equity ratio of 0.25 suggests a relatively conservative capital structure, with equity financing playing a dominant role in the company's capital base. In terms of profitability, the company's return on equity (ROE) of 13.55% and return on assets (ROA) of 10.01% are strong indicators of efficient use of equity and assets to generate profits. These metrics are well above the typical thresholds for the Commodity Chemicals industry, suggesting that Beezaasan Explotech is outperforming its peers in terms of profitability. The company's revenue is primarily concentrated in the Indian market, with a significant portion of its business tied to the cement, mining, and defense industries. It supplies to the Border Roads Organization and Public Sector Undertakings, indicating a strong government and public sector presence. This concentration may pose risks if demand from these sectors fluctuates. Looking at the growth trajectory, Beezaasan Explotech has demonstrated a consistent revenue stream, with a revenue of INR 2,149,950,870. The company's operating cash flow of INR 51,075,310 and free cash flow of INR 93,221,560 indicate a healthy cash generation capability, which supports its capital expenditure of INR -72,105,020. These figures suggest that the company is investing in its operations to sustain and potentially accelerate growth. The risk assessment for Beezaasan Explotech highlights a medium liquidity risk and a low dilution risk. The company's capital structure is relatively stable, with a low probability of near-term dilution. However, the negative net cash position after subtracting total debt is a key flag that investors should monitor closely. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on its core business of manufacturing and supplying explosives, with no major new initiatives or strategic shifts reported in the latest filings.
Key takeaways
  • Beezaasan Explotech has a strong profitability profile with ROE and ROA well above industry norms.
  • The company's conservative capital structure and high current ratio suggest a stable financial position.
  • Revenue concentration in the Indian market and reliance on government contracts may pose operational risks.
  • The company's liquidity position is medium, with a negative net cash position after subtracting total debt.
  • Beezaasan Explotech is investing in its operations, as evidenced by its capital expenditure and free cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$2.15B
Gross profit$279.8M
Operating income$206.7M
Net income$131.2M
R&D
SG&A
D&A
SBC
Operating cash flow$51.1M
CapEx-$72.1M
Free cash flow$93.2M
Total assets$1.31B
Total liabilities$342.8M
Total equity$968.4M
Cash & equivalents
Long-term debt$246.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$968.4M
Net cash-$246.1M
Current ratio3.5
Debt/Equity0.2
ROA10.0%
ROE13.6%
Cash conversion39.0%
CapEx/Revenue-3.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricBEEZActivity
Op margin9.6%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin13.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity25.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 13:52 UTC#90374735
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 14:37 UTCJob: 055971bf